Alkermes (ALKS) Current Leases (2019 - 2026)
Alkermes (ALKS) posted quarterly Current Leases of $7.5 million for Q2 2026, up 15.71% year-over-year from $6.5 million in Q2 2025, and down 1.32% quarter-over-quarter from $7.6 million in Q1 2026.
Alkermes (ALKS) Current Leases (2019 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Current Leases for 8 consecutive years, with $7.5 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Leases rose 15.71% year-over-year to $7.5 million; the TTM figure through Jun 2026 stood at $7.5 million (up 15.71% YoY), while the FY2025 annual figure was $6.7 million, up 9.41% from the prior year.
- Current Leases slipped to $7.5 million in Q2 2026 per ALKS's latest filing, from $7.6 million in the prior quarter.
- Across five years, Current Leases topped out at $16.1 million in Q1 2022 and bottomed at $5.7 million in Q4 2023.
- Historically, Current Leases has averaged $9.7 million across 5 years, with a median of $7.1 million in 2025.
- Annual changes were most pronounced in 2024 — Current Leases tumbled 61.38% — and 2026, when it climbed 20.44%.
- Alkermes' Current Leases stood at $9.9 million in 2022, then plunged by 41.83% to $5.7 million in 2023, then gained by 7.31% to $6.2 million in 2024, then climbed by 9.41% to $6.7 million in 2025, then grew by 10.84% to $7.5 million in 2026.
- Business Quant data shows ALKS's Current Leases at $7.5 million in Q2 2026, $7.6 million in Q1 2026, and $6.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Alkermes | 8.12 Bn | 7.46 Bn | 397.90 Mn | 7.48 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.48 Mn |
| Mar 31, 2026 | 7.58 Mn |
| Dec 31, 2025 | 6.75 Mn |
| Sep 30, 2025 | 6.63 Mn |
| Jun 30, 2025 | 6.46 Mn |
| Mar 31, 2025 | 6.29 Mn |
| Dec 31, 2024 | 6.17 Mn |
| Sep 30, 2024 | 6.15 Mn |
| Jun 30, 2024 | 6.01 Mn |
| Mar 31, 2024 | 5.91 Mn |
| Dec 31, 2023 | 5.75 Mn |
| Sep 30, 2023 | 15.06 Mn |
| Jun 30, 2023 | 15.19 Mn |
| Mar 31, 2023 | 15.30 Mn |
| Dec 31, 2022 | 9.88 Mn |
| Sep 30, 2022 | 15.76 Mn |
| Jun 30, 2022 | 15.94 Mn |
| Mar 31, 2022 | 16.14 Mn |
| Dec 31, 2021 | 16.24 Mn |
| Sep 30, 2021 | 15.55 Mn |